key: cord-0945513-8rhiw1xq
authors: Feng, Ruirui; Wang, Bing; Ma, Zhuang; Guo, Xiaozhong; Li, Hongyu; Tang, Yufu; Meng, Hao; Yu, Hao; Peng, Chengfei; Chu, Guiyang; Wang, Xinwei; Teng, Yue; Zhang, Quanyu; Zhu, Tianyi; Tong, Zhenhua; Zhao, Haitao; Lu, Hui; Qi, Xingshun
title: Dynamic change of serum albumin level can predict the prognosis of COVID‐19 patients with hypoalbuminemia
date: 2021-11-16
journal: J Med Virol
DOI: 10.1002/jmv.27439
sha: 4d1deb9c747b848b649c98d68c59dd6a5a130312
doc_id: 945513
cord_uid: 8rhiw1xq

Hypoalbuminemia usually predicts higher mortality, longer hospital stay, and more frequent re-admission1 . About 40%-60% of COVID-19 patients develop hypoalbuminemia at admission2, 3 . This may be due to an increase of capillary permeability caused by systemic inflammatory response4 , which leads to the leakage of serum albumin into interstitial space5 , poor nutritional status, and impaired liver function1 . COVID-19 patients with hypoalbuminemia are more severe and/or critical2 , and have a higher probability of intensive care unit (ICU) admission and higher risk of death6, 7 . However, few studies have evaluated the dynamic change of serum albumin level in COVID-19 patients with hypoalbuminemia on the patients' death. This article is protected by copyright. All rights reserved.

The severity of COVID-19 patients was classified into mild, moderate, severe, and critical according to the New Coronavirus Pneumonia Prevention and Control Program published by the National Health Commission of China. 8 The reference range of serum ALB level is 40-55 g/L at this hospital. Hypoalbuminemia is defined as a serum ALB level of <35 g/L. 9 Baseline serum ALB level refers to serum ALB level obtained when hypoalbuminemia was found for the first time at admission or during hospitalization. In the human ALB infusion group, ΔALB is defined as serum ALB level obtained on the first retest after human ALB infusion minus baseline serum ALB level; in the nonhuman ALB infusion group, ΔALB is defined as serum ALB level obtained on the second test after hospitalization minus baseline serum ALB level.

Continuous variables were described using mean ± standard deviations and compared by the Mann-Whitney U test or the Student ttest. Categorical variables were described using percentages and compared by the χ 2 test. Univariate and multivariate logistic regression analyses were conducted to explore the predictors of death in COVID-19 patients. The receiver operating curve (ROC) analysis was used to explore the predictive performance of ΔALB for death. Data analysis was performed using SPSS version 20.0 (IBM Corp) and

MedCalc version 11.4.2.0 (MedCalc Software). A two-tailed p < 0.05 was considered to be statistically significant.

A total of 535 COVID-19 patients with hypoalbuminemia were included in the present study. There were 297 (55.50%) males, and the median age was 67 years. Among them, 163 (30.50%) patients received human ALB infusion, and 40 (7.50%) died.

Patients who died had a significantly lower ΔALB (0.90 vs. 2.60, p < 0.001) than those who survived (Table 1) In conclusion, a reduction of serum ALB level seems to be a predictor for the death of COVID-19 patients with hypoalbuminemia, regardless of human ALB infusion. This can be explained by the possibility that reduced serum ALB levels can reflect a deterioration in liver dysfunction and malnutrition, which will further lead to worse outcomes.

We are indebted to all of the medical staff who volunteered to parti- Abbreviations: ALB, albumin; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; CRP, C-reactive protein; Hb, Hemoglobin; INR, international normalized ratio; PLT, platelet count; PT, prothrombin time; Pts, patients; TBIL, total bilirubin; WBC, white blood cell.

The meaning of hypoalbuminaemia in clinical practice

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis

Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China

Hypoalbuminemia: pathogenesis and clinical significance

Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity

Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: a systematic review and meta-analysis

General Office of National Health Commission of the People's Republic of China. Diagnosis and treatment of corona virus disease-19

Hypoalbuminemia and obesity in orthopaedic trauma patients: body mass index a significant predictor of surgical site complications